U.S. Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps and Continuous Rate Elastomeric Pumps), By Indication ( Oncology, Post-operative Care, General Medicine, and Others), By End User ( Ambulatory Surgical Centers, Clinics, Home Care Settings ( Oncology, Post-operative Care, General Medicine & Others ), Hospitals and Others), is estimated to be valued at US$ 258.3 million in 2021 and is expected to exhibit a CAGR of 5.7 % during the forecast period (2022-2028), as highlighted in a new report published by Coherent Market Insights.
Get Your FREE Sample Copy of the U.S. Elastomeric Infusion Pumps Market Report 2021
Key players operating in the market are focusing on the development of technologically advanced infusion pumps.
For instance, in May 2018, Nipro Corporation, a medical equipment company, launched New SUREFUSER + PCA SET. This device is used for the continuous infusion of an anesthetic which is controlled by a patient according to the level of pain. It is easy to grab and fit in a palm, with a larger button as the switch for injection of drug solution.
U.S. Elastomeric Infusion Pumps Market – Impact of Coronavirus (Covid-19) Pandemic
The coronavirus (COVID-19) outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. The U.S. was amongst the most affected countries during the early stage of the COVID-19 pandemic. Till date the country has a cumulative count of around 31,742,914 cases since the start of the pandemic.
The increasing number of COVID-19 patients has brought a shift in the healthcare infrastructure. Hospitals & clinics are focusing on delivering medication through infusion pumps, for precise administration of specific amounts of medication. In addition, the healthcare organizations are issuing new guidelines for promoting the use of infusion pumps.
View Press Release For More Information
For instance, in May 2020, the U.S. FDA has issued authorization for the use of infusion pumps and associated accessories for treating Covid-19 patients. In addition, the U.S. FDA instructed manufacturing companies to provide instructions and guidelines for cleaning the reusable devices for encouraging their application in home care settings.
Similarly, in April 2020, the U.S. FDA issued policies to expand the remote capabilities and availability of infusion pumps for healthcare professionals during the pandemic. Hence, the COVID-19 pandemic has positive effect on the overall infusion pump market growth.
However, the COVID-19 effect on the elastomeric infusion pump market can be termed moderate. This is owing to the limited studies on the use of elastomeric infusion pumps for treating the coronavirus infected patients hence, the government initiatives are more inclined towards IV infusion pumps and smart pumps.
Browse 10 Market Data Tables and 19 Figures spread through 106 Pages and in-depth TOC on ‘U.S. Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps and Continuous Rate Elastomeric Pumps), By Indication (Oncology, Post-operative Care, General Medicine, and Others), By End User (Ambulatory Surgical Centers, Clinics, Home Care Settings (Oncology, Post-operative Care, General Medicine, & Others), Hospitals, and Others)
Buy Now This Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/4452
Reasons to Purchase this Report
• Current and future of global U.S. Elastomeric Infusion Pumps market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/4452
Key players operating in the market are focusing on strategic investments in order to increase their manufacturing capacity and product development capacity, which will help them to increase their market presence.
In 2020, Baxter International Inc., a medical device company, invested around US$ 521 Mn on research and development programs to enhance future growth through clinical differentiation. The investment in research and development (R&D), consistent with portfolio optimization, and capital allocation strategies, helps to fuel the company’s future growth and ability to remain competitive in each of the product categories.
Key Takeaways of the U.S. Elastomeric Infusion Pumps Market:
- The U.S. elastomeric infusion pumps market is expected to exhibit a CAGR of 5.7 % during the forecast period, owing to increasing incidence of chronic diseases such as cancer and advantages of elastomeric pumps
- Among product type, continuous rate elastomeric pumps segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to the increasing product offerings of automated and technologically advanced continuous rate elastomeric pumps by major players in the market
- Among indication, oncology segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to increasing incidence of cancer in the U.S
- Among end user type, hospital segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to increasing hospital spending by cancer patients in the U.S. for treatment of cancers
- Key players operating in the U.S. elastomeric infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Werfen, Ambu A/S, Avanos Medical Inc., NIPRO, and Progressive Medical, Inc.
Ask for PDF sample copy of the U.S. Elastomeric Infusion Pumps market report @ https://www.coherentmarketinsights.com/insight/request-pdf/4452
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Collaboration & Acquisition
- Market Trends
- Regulatory Scenario
- PEST Analysis
- Major Brand Analysis
- Disposable Balloon Infusion Pump VS Electric/Programmable Infusion Control System
- Pricing Analysis
- U.S. Elastomeric Infusion Pumps Market – Impact of COVID-19 Pandemic
- Impact on Supply and Demand
- Impact on Overall Healthcare
- Government Initiatives
- U.S. Elastomeric Infusion Pumps Market, By Product Type, 2017-2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018–2028
- Segment Trends
- Variable Rate Elastomeric Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Continuous Rate Elastomeric Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Variable Rate Elastomeric Pumps
- Introduction
- U.S. Elastomeric Infusion Pumps Market, By Indication , 2017-2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018–2028
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Post-operative Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- General Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Oncology
- Introduction
- U.S. Elastomeric Infusion Pumps Market, By End User, 2017–2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018–2028
- Segment Trends
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Oncology
- Post-operative Care
- General Medicine
- Others
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Competitive Landscape
- Company Profiles
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837